[go: up one dir, main page]

ES2102994T3 - Derivados de benzisotiazolinona-1-dioxido como inhibidores de elastasa. - Google Patents

Derivados de benzisotiazolinona-1-dioxido como inhibidores de elastasa.

Info

Publication number
ES2102994T3
ES2102994T3 ES91301895T ES91301895T ES2102994T3 ES 2102994 T3 ES2102994 T3 ES 2102994T3 ES 91301895 T ES91301895 T ES 91301895T ES 91301895 T ES91301895 T ES 91301895T ES 2102994 T3 ES2102994 T3 ES 2102994T3
Authority
ES
Spain
Prior art keywords
group
compositions
dioxide
benzisotiazolinone
saturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91301895T
Other languages
English (en)
Inventor
Ladislas Robert
Elemer Moczar
William Georges Hornebeck
Christiane Marie-Pierr Kerneur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of ES2102994T3 publication Critical patent/ES2102994T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS Y COSMETICAS COMPRENDIENDO AL MENOS UN DERIVADO DE DIOXIDO-1-BENCISOTIAZOLINONO CON LA FORMULA: DONDE R ELEVADO 1 PUEDE SER HIDROGENO, Y R ELEVADO 2 PUEDE SER CIERTOS GRUPOS GENERALMENTE ALIFATICOS HIDROFOBICOS C SUB 8-C SUB 20 O EL GRUPO: DONDE R ELEVADO 5 ES ALIFATICO U OTRO R (AL CUADRADO) ES UN GRUPO C SUB 2-C SUB 8 SATURADO O NO SATURADO ACABANDO EN UN NUCLEO AROMATICO. ESTAS COMPOSICIONES PUEDEN SER UTILIZADAS PARA INHIBIR ELASTASOS TALES COMO ELASTASO LEUCOCITICO HUMANO. DEBEN DE SER APLICADAS TOPICAMENTE COMO COSMETICO. MUCHOS DE LOS DERIVADOS DE DIOXIDO-2-BENZISOTIAZOLINONO ESPECIFICADO COMO UN INGREDIENTE ACTIVO EN DICHAS COMPOSICIONES SON COMPUESTOS NUEVOS.
ES91301895T 1990-03-08 1991-03-07 Derivados de benzisotiazolinona-1-dioxido como inhibidores de elastasa. Expired - Lifetime ES2102994T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9002951A FR2659327A1 (fr) 1990-03-08 1990-03-08 Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.

Publications (1)

Publication Number Publication Date
ES2102994T3 true ES2102994T3 (es) 1997-08-16

Family

ID=9394523

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91301895T Expired - Lifetime ES2102994T3 (es) 1990-03-08 1991-03-07 Derivados de benzisotiazolinona-1-dioxido como inhibidores de elastasa.

Country Status (16)

Country Link
US (2) US5338747A (es)
EP (1) EP0446047B1 (es)
JP (1) JPH04234863A (es)
KR (1) KR960014782B1 (es)
AT (1) ATE154347T1 (es)
AU (1) AU636013B2 (es)
BR (1) BR9100938A (es)
CA (1) CA2037665A1 (es)
DE (1) DE69126460T2 (es)
ES (1) ES2102994T3 (es)
FR (1) FR2659327A1 (es)
ID (1) ID820B (es)
IN (1) IN172035B (es)
MY (1) MY106067A (es)
TW (1) TW200472B (es)
ZA (1) ZA911728B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5250696A (en) * 1990-11-01 1993-10-05 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylate
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (es) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
US6375948B1 (en) * 1999-07-12 2002-04-23 Kao Corporation Treating method for suppressing hair growth
GB0129987D0 (en) * 2001-12-14 2002-02-06 Zylepsis Ltd Skin compositions
US7361767B2 (en) 2003-11-14 2008-04-22 3M Innovative Properties Company N-sulfonyldicarboximide containing tethering compounds
US7423155B2 (en) 2003-11-14 2008-09-09 3M Innovative Properties Company N-sulfonyldicarboximide containing tethering compounds
WO2005049590A2 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company N-sulfonylaminocarbonyl containing compounds
US7169933B2 (en) 2003-11-14 2007-01-30 3M Innovative Properties Company N-sulfonylaminocarbonyl containing compounds
US7943388B2 (en) 2003-11-14 2011-05-17 3M Innovative Properties Company Acoustic sensors and methods
WO2005066121A2 (en) * 2003-12-30 2005-07-21 3M Innovative Properties Company Multifunctional amine capture agents
US7402678B2 (en) 2004-12-17 2008-07-22 3M Innovative Properties Company Multifunctional amine capture agents
US7342082B2 (en) 2004-12-17 2008-03-11 3M Innovative Properties Company Soluble polymers as amine capture agents and methods
US7544754B2 (en) 2005-09-30 2009-06-09 3M Innovative Properties Company Crosslinked polymers with amine binding groups
US7544755B2 (en) 2005-09-30 2009-06-09 3M Innovative Properties Company Crosslinked polymers with amine binding groups
US7544756B2 (en) 2005-09-30 2009-06-09 3M Innovative Properties Company Crosslinked polymers with amine binding groups
US8034448B2 (en) * 2008-08-19 2011-10-11 Los Alamos National Security, Llc Fibrous composites comprising carbon nanotubes and silica
AR079232A1 (es) 2009-12-01 2012-01-04 Lubrizol Advanced Mat Inc Polimeros multiproposito estables hidroliticamente
CN110225752B (zh) 2016-09-12 2023-05-05 整体健康 用作gpr120调节器的单环化合物
CA3041038A1 (en) 2016-09-12 2018-03-15 Numerate, Inc. Bicyclic compounds useful as gpr120 modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase

Also Published As

Publication number Publication date
FR2659327A1 (fr) 1991-09-13
DE69126460D1 (de) 1997-07-17
DE69126460T2 (de) 1997-12-04
ATE154347T1 (de) 1997-06-15
AU636013B2 (en) 1993-04-08
IN172035B (es) 1993-03-20
US5338747A (en) 1994-08-16
KR910016330A (ko) 1991-11-05
EP0446047B1 (en) 1997-06-11
TW200472B (es) 1993-02-21
EP0446047A1 (en) 1991-09-11
US5411978A (en) 1995-05-02
JPH04234863A (ja) 1992-08-24
CA2037665A1 (en) 1991-09-09
MY106067A (en) 1995-03-31
ID820B (id) 1996-07-22
ZA911728B (en) 1992-11-25
AU7263591A (en) 1991-09-12
BR9100938A (pt) 1991-11-05
KR960014782B1 (en) 1996-10-19

Similar Documents

Publication Publication Date Title
ES2102994T3 (es) Derivados de benzisotiazolinona-1-dioxido como inhibidores de elastasa.
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
ES2069410T3 (es) Nuevos derivados del acido hidroxamico y n-hidroxiurea y su uso.
ES2179353T3 (es) Antagonistas muscarinicos.
NO951162L (no) 1-(2-okso-acetyl)-piperidin-2-karboksylsyrederivater som multi-medikamentresistente sensitivisatorer for kreftceller
ES2084944T3 (es) Amidas terapeuticas.
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
ES2056214T3 (es) Compuestos de benzopirido-piperidina, -piperidilideno y -piperazina, composiciones, metodos de preparacion y metodos de uso.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
IT1223313B (it) Derivati di acidi biliari loro preparazione e composizioni farmaceutiche che li contengono
NO940523L (no) Nye pyrazin-derivater
AR007021A1 (es) Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos
AR001931A1 (es) Compuesto de 7-acilamino-3-iminometil (sustituido)cefalosporinas un proceso para su producción intermediarios en su producción una composición farmacéutica que contiene tales compuestos su utilizacióncomo compuestos farmacéuticos y un método para tratar enfermedades microbianas mediante administración de tales compuestos
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
ES2045189T3 (es) Nuevos agentes anti-arritmicos i.
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
MX9401080A (es) Compuestos heteroaromaticos.
ES2091183T3 (es) Metodo para mejorar el sueño.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
AR009251A1 (es) Compuestos de ácido 4-oxo-butanoico y composiciones que los contienen
AR045912A1 (es) Composiciones farmaceuticas que contienen derivados de azetidina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 446047

Country of ref document: ES